Abstract
Background/purpose
In June 2004, a critical pathway for patients undergoing pancreaticoduodenectomy (PD) was introduced. The objective of this study was to determine the clinical value of critical pathway implementation.
Methods
256 consecutive patients who underwent PD between 2000 and 2010 were divided into 4 groups by date of operation as follows; group A (n = 77), the pre-pathway group; group B (n = 51), the CP implementation group who were managed according to departmental guidelines; group C (n = 78), the group who had no stenting in the reconstruction of PD; and group D (n = 50), the group who had reinforcement of the pancreaticojejunostomy. The success rates of clinical outcomes and post-operative morbidity were compared between each group, year by year and every 50 patients.
Results
The success rates of clinical outcomes, including the timings of nasogastric tube removal, discontinuation of prophylactic anti-microbial agent, drain removal, starting oral intake, and patient discharge, were significantly improved in group B relative to group A, and in group C relative to group B. There were no significant differences in mortality and morbidity between any of the groups. All clinical outcomes reached a plateau at 2–3 years or 100–150 patients’ operations after critical pathway implementation.
Conclusions
Long-term use of a critical pathway is associated with improved clinical outcomes. A certain period of time or volume of patients is needed for this improvement in clinical outcomes to reach a plateau, which indicates achieving standardization of peri-operative management.
Similar content being viewed by others
References
Neoptolemos JP, Russel RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and peri-ampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg. 1997;84:1370–6.
Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg. 1997;226:248–60.
Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.
Gouillat C, Gigot JF. Pancreatic surgical complications—the case for prophylaxis. Gut. 2001;49:32–9.
Satoi S, Takai S, Matsui Y, Terakawa N, Iwaki R, Fukui J, et al. Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer. Pancreas. 2006;33:45–52.
Muller S, Zalunardo MP, Hubner M, Clavien PA, Zurich Fast Track Study Group. A fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology. 2009;136:842–7.
Pritts TA, Nussbaum MS, Flesch LV, Fegelman EJ, Parikh AA, Fischer JE. Implementation of a clinical pathway decreases length of stay and cost for bowel resection. Ann Surg. 1999;230:728–33.
Cerfolio RJ, Bryant AS, Bass CS, Alexander JR, Bartolucci AA. Fast tracking after Ivor Lewis esophagogastrectomy. Chest. 2004;126:1187–94.
Huber TS, Carlton LM, Harward TRS, Russin MM, Phillips PT, Nalli BJ, et al. Impact of a clinical pathway for elective infrarenal aortic reconstructions. Ann Surg. 1998;227:691–701.
Leibman BD, Dillioglugil O, Abbas F, Tanli S, Kattan MW, Scardino PT. Impact of a clinical pathway for radical retropubic prostatectomy. Urology. 1998;52:94–9.
Markey DW, McGowan J, Hanks JB. The effect of clinical pathway implementation on total hospital costs for thyroidectomy and parathyroidectomy patients. Am Surg. 2000;66:533–8.
Kennedy EP, Rosato EL, Sauter PK, Rosenberg LM, Doria C, Marino IR, et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution—the first step in multidisciplinary team building. J Am Coll Surg. 2007;204:917–24.
Vanounou T, Pratt W, Fischer JE, Vollmer CM, Callery MP. Deviation-based cost modeling: a novel model to evaluate the clinical and economic impact of clinical pathways. J Am Coll Surg. 2007;204:570–9.
Porter GA, Pisters PW, Mansyur C, Bisanz A, Kim R, Stanford P, et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol. 2000;7:484–9.
Balzano G, Zerbi A, Braga M, Rocchetti S, Beneduce AA, Di Carlo V. Fast-track recovery programme after pancreaticoduodenectomy reduces delayed gastric emptying. Br J Surg. 2008;95:1387–93.
Pitt HA, Murray KP, Bowman HM, Coleman JA, Gordon TA, Yeo CJ, et al. Clinical pathway implementation improves outcomes for complex biliary surgery. Surgery. 1999;126:751–8.
Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Yamao J, Kim S, et al. A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. Pancreas. 2008;37:128–33.
Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Hirooka S, Yui R, et al. Is a nonstented duct-to-mucosa anastomosis using the modified Kakita method a safe procedure? Pancreas. 2010;39:165–70.
Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Hirooka S, Yui R, et al. Reinforcement of pancreaticojejunostomy using polyglycolic acid mesh and fibrin glue sealant. Pancreas. 2011;40:16–20.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.
Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316:133–7.
Kawai M, Tani M, Terasawa H, Ina S, Hirono S, Nishioka R, et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg. 2006;244:1–7.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yamaki, S., Satoi, S., Toyokawa, H. et al. The clinical role of critical pathway implementation for pancreaticoduodenectomy in 179 patients. J Hepatobiliary Pancreat Sci 20, 271–278 (2013). https://doi.org/10.1007/s00534-012-0506-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-012-0506-x